| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dizocilpine Maleate | 2 | 2018 | 7 | 0.79 | Why? |
| Nuclear Power Plants | 1 | 2018 | 18 | 0.73 | Why? |
| Endovascular Procedures | 2 | 2019 | 1302 | 0.72 | Why? |
| Ocular Motility Disorders | 1 | 2018 | 55 | 0.72 | Why? |
| Temporal Lobe | 1 | 2018 | 83 | 0.71 | Why? |
| Mechanical Thrombolysis | 1 | 2019 | 150 | 0.70 | Why? |
| Thrombocythemia, Essential | 1 | 2019 | 141 | 0.70 | Why? |
| Vertigo | 1 | 2018 | 141 | 0.69 | Why? |
| Neoplasms, Radiation-Induced | 1 | 2018 | 60 | 0.68 | Why? |
| Carotid Artery, Internal | 1 | 2018 | 97 | 0.67 | Why? |
| Brain Infarction | 1 | 2018 | 129 | 0.66 | Why? |
| Brain Edema | 1 | 2019 | 224 | 0.64 | Why? |
| Brain Ischemia | 5 | 2019 | 2813 | 0.64 | Why? |
| Cerebral Hemorrhage | 3 | 2019 | 820 | 0.60 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2018 | 203 | 0.60 | Why? |
| Potassium Channels, Voltage-Gated | 1 | 2014 | 13 | 0.59 | Why? |
| Muscle, Smooth, Vascular | 1 | 2014 | 86 | 0.54 | Why? |
| Myocytes, Smooth Muscle | 1 | 2014 | 127 | 0.52 | Why? |
| Stroke | 7 | 2019 | 8839 | 0.43 | Why? |
| Stents | 1 | 2018 | 916 | 0.42 | Why? |
| White Matter | 3 | 2018 | 369 | 0.39 | Why? |
| Transcription Factor RelA | 2 | 2018 | 122 | 0.35 | Why? |
| Isoflurane | 2 | 2017 | 38 | 0.34 | Why? |
| Republic of Korea | 8 | 2021 | 5858 | 0.33 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.33 | Why? |
| Middle Cerebral Artery | 2 | 2017 | 128 | 0.32 | Why? |
| Thrombectomy | 1 | 2018 | 2272 | 0.31 | Why? |
| Pruritus | 2 | 2017 | 215 | 0.29 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.28 | Why? |
| Cnidium | 1 | 2003 | 7 | 0.27 | Why? |
| Hand Dermatoses | 2 | 2017 | 284 | 0.24 | Why? |
| Inflammasomes | 2 | 2018 | 710 | 0.23 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.22 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-1 | 2 | 2017 | 17 | 0.22 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.22 | Why? |
| Hippocampus | 1 | 2003 | 237 | 0.21 | Why? |
| Tissue Plasminogen Activator | 2 | 2017 | 778 | 0.21 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.21 | Why? |
| Microglia | 1 | 2003 | 357 | 0.20 | Why? |
| Intranuclear Space | 1 | 2018 | 2 | 0.19 | Why? |
| Patch-Clamp Techniques | 2 | 2018 | 49 | 0.19 | Why? |
| MAP Kinase Kinase Kinase 5 | 1 | 2018 | 16 | 0.19 | Why? |
| Kv1.5 Potassium Channel | 1 | 2018 | 1 | 0.19 | Why? |
| Serotonin 5-HT2 Receptor Agonists | 1 | 2018 | 3 | 0.19 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.19 | Why? |
| Potassium Channel Blockers | 1 | 2018 | 22 | 0.19 | Why? |
| Neurons | 2 | 2017 | 864 | 0.19 | Why? |
| Korea | 1 | 2018 | 89 | 0.18 | Why? |
| Cerebral Angiography | 2 | 2018 | 391 | 0.18 | Why? |
| Lipopolysaccharides | 1 | 2003 | 848 | 0.18 | Why? |
| Subcutaneous Fat, Abdominal | 1 | 2017 | 3 | 0.18 | Why? |
| Sclerosing Solutions | 1 | 2017 | 4 | 0.18 | Why? |
| Sclerotherapy | 1 | 2017 | 23 | 0.18 | Why? |
| p120 GTPase Activating Protein | 1 | 2017 | 1 | 0.18 | Why? |
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 39 | 0.18 | Why? |
| Dermatitis, Photoallergic | 1 | 2017 | 8 | 0.18 | Why? |
| Port-Wine Stain | 1 | 2017 | 8 | 0.17 | Why? |
| Chromosomes, Human, Pair 5 | 1 | 2017 | 38 | 0.17 | Why? |
| Capillaries | 2 | 2017 | 257 | 0.17 | Why? |
| Ischemic Postconditioning | 1 | 2017 | 13 | 0.17 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.17 | Why? |
| Vascular Malformations | 1 | 2017 | 52 | 0.17 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 92 | 0.17 | Why? |
| Chromosome Deletion | 1 | 2017 | 62 | 0.17 | Why? |
| Erythropoiesis | 1 | 2017 | 71 | 0.16 | Why? |
| Arteriovenous Malformations | 1 | 2017 | 33 | 0.16 | Why? |
| Hepcidins | 1 | 2017 | 97 | 0.16 | Why? |
| Skin Diseases, Vascular | 1 | 2017 | 69 | 0.16 | Why? |
| Cystatin C | 1 | 2017 | 125 | 0.16 | Why? |
| Bleomycin | 1 | 2017 | 195 | 0.16 | Why? |
| Ketamine | 1 | 2018 | 112 | 0.16 | Why? |
| Acrodermatitis | 1 | 2017 | 60 | 0.16 | Why? |
| Matrix Metalloproteinases | 1 | 2017 | 131 | 0.16 | Why? |
| Scabies | 1 | 2017 | 75 | 0.16 | Why? |
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 143 | 0.15 | Why? |
| Astrocytes | 1 | 2018 | 298 | 0.15 | Why? |
| Nitric Oxide | 1 | 2003 | 769 | 0.15 | Why? |
| Obesity, Abdominal | 1 | 2017 | 167 | 0.15 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Membrane Potentials | 1 | 2014 | 56 | 0.15 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.14 | Why? |
| Herpes Zoster Oticus | 1 | 2014 | 3 | 0.14 | Why? |
| Stereoisomerism | 1 | 2014 | 121 | 0.14 | Why? |
| Behcet Syndrome | 1 | 2016 | 136 | 0.14 | Why? |
| Intra-Abdominal Fat | 1 | 2017 | 227 | 0.14 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.14 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.14 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.13 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.13 | Why? |
| Male | 27 | 2021 | 367725 | 0.13 | Why? |
| Eczema | 1 | 2017 | 227 | 0.13 | Why? |
| Ischemic Attack, Transient | 1 | 2017 | 439 | 0.13 | Why? |
| Central Nervous System Stimulants | 1 | 2014 | 111 | 0.13 | Why? |
| Heart Valve Diseases | 1 | 2018 | 355 | 0.13 | Why? |
| Magnetic Resonance Imaging | 3 | 2019 | 6551 | 0.12 | Why? |
| Cervical Vertebrae | 1 | 2014 | 151 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.12 | Why? |
| Intracranial Hemorrhages | 2 | 2018 | 1170 | 0.12 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.12 | Why? |
| Rats | 2 | 2014 | 2764 | 0.12 | Why? |
| Herpesvirus 3, Human | 1 | 2014 | 228 | 0.12 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.12 | Why? |
| Aged | 15 | 2021 | 215776 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.11 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.11 | Why? |
| Calcinosis | 1 | 2014 | 240 | 0.11 | Why? |
| Pyridones | 1 | 2017 | 738 | 0.11 | Why? |
| Carotid Artery Diseases | 1 | 2014 | 251 | 0.11 | Why? |
| Dermatologic Agents | 1 | 2017 | 489 | 0.11 | Why? |
| Drug Hypersensitivity | 1 | 2017 | 401 | 0.11 | Why? |
| Proteins | 1 | 2018 | 921 | 0.10 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2018 | 882 | 0.10 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.10 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 595 | 0.10 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.10 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.10 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.10 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.09 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2018 | 1365 | 0.09 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.09 | Why? |
| Anti-Inflammatory Agents | 2 | 2017 | 6153 | 0.09 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 441 | 0.09 | Why? |
| Infant | 3 | 2021 | 30274 | 0.09 | Why? |
| Mice, Inbred ICR | 2 | 2018 | 242 | 0.09 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Apoptosis Regulatory Proteins | 2 | 2018 | 202 | 0.08 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.08 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.08 | Why? |
| Treatment Outcome | 5 | 2019 | 51732 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.07 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.07 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.07 | Why? |
| Animals | 10 | 2021 | 78931 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.07 | Why? |
| Drug Approval | 1 | 2014 | 1325 | 0.07 | Why? |
| Cell Survival | 2 | 2017 | 1581 | 0.07 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 502 | 0.07 | Why? |
| Mortality | 2 | 2018 | 7132 | 0.07 | Why? |
| Nitric Oxide Synthase | 1 | 2003 | 37 | 0.07 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2003 | 119 | 0.06 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.06 | Why? |
| Plant Roots | 1 | 2003 | 108 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Child | 4 | 2021 | 70012 | 0.06 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Retrospective Studies | 6 | 2019 | 105322 | 0.06 | Why? |
| Brain | 2 | 2016 | 5133 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Acetates | 1 | 2003 | 123 | 0.06 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Mice | 5 | 2018 | 21357 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Cell Death | 1 | 2003 | 536 | 0.05 | Why? |
| Blotting, Western | 1 | 2003 | 863 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Administration, Oral | 2 | 2017 | 2340 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| In Vitro Techniques | 1 | 2003 | 1027 | 0.05 | Why? |
| Receptor, Serotonin, 5-HT2A | 1 | 2018 | 6 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Protein Stability | 1 | 2021 | 756 | 0.05 | Why? |
| Cell Line | 3 | 2019 | 12040 | 0.04 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.04 | Why? |
| MEF2 Transcription Factors | 1 | 2017 | 8 | 0.04 | Why? |
| Microfilament Proteins | 1 | 2017 | 45 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Receptors, LDL | 1 | 2017 | 42 | 0.04 | Why? |
| Hematinics | 1 | 2017 | 48 | 0.04 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2017 | 138 | 0.04 | Why? |
| Culture Media, Conditioned | 1 | 2017 | 66 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2019 | 8843 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.04 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.04 | Why? |
| Sensation Disorders | 1 | 2017 | 103 | 0.04 | Why? |
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2017 | 80 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Calcium-Binding Proteins | 1 | 2017 | 121 | 0.04 | Why? |
| Cyclooxygenase 2 | 1 | 2017 | 129 | 0.04 | Why? |
| Cell Hypoxia | 1 | 2017 | 141 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Endothelial Cells | 2 | 2017 | 2048 | 0.04 | Why? |
| Vascular Resistance | 1 | 2017 | 148 | 0.04 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.04 | Why? |
| CD4 Antigens | 1 | 2017 | 306 | 0.04 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.04 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.04 | Why? |
| Spinal Cord | 1 | 2017 | 281 | 0.04 | Why? |
| CHO Cells | 1 | 2018 | 831 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Touch | 1 | 2017 | 180 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Cricetulus | 1 | 2018 | 936 | 0.04 | Why? |
| Rhinovirus | 1 | 2021 | 979 | 0.04 | Why? |
| Drug Compounding | 1 | 2017 | 386 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.04 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.03 | Why? |
| Government Regulation | 1 | 2021 | 842 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.03 | Why? |
| Marketing | 1 | 2014 | 195 | 0.03 | Why? |
| Intestines | 1 | 2018 | 817 | 0.03 | Why? |
| Sample Size | 1 | 2014 | 518 | 0.03 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
| Plant Extracts | 1 | 2003 | 1514 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.02 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| United States Food and Drug Administration | 1 | 2014 | 1276 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2016 | 7220 | 0.01 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2014 | 7330 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2016 | 31397 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Prospective Studies | 1 | 2014 | 43301 | 0.01 | Why? |
| United States | 1 | 2014 | 46150 | 0.01 | Why? |
| Risk Factors | 1 | 2014 | 71621 | 0.00 | Why? |
| Pandemics | 1 | 2021 | 389249 | 0.00 | Why? |